147 related articles for article (PubMed ID: 38438837)
21. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
Alkatan HM; AlQahtani FS; Maktabi AM
Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for recurrent retinoblastoma after intravenous chemotherapy.
Kaliki S; Vempuluru VS; Priya Y; Mohamed A
Int Ophthalmol; 2021 Jun; 41(6):2033-2039. PubMed ID: 33611762
[TBL] [Abstract][Full Text] [Related]
23. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
Lee V; Subak-Sharpe I; Hungerford JL; Davies NP; Logani S
Ophthalmology; 2000 May; 107(5):940-5; discussion 946. PubMed ID: 10811087
[TBL] [Abstract][Full Text] [Related]
24. The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma.
Mou J; Yang L; Zhao J; Ni X
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1313-1318. PubMed ID: 36357738
[TBL] [Abstract][Full Text] [Related]
25. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.
Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brennan RC; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa-Llano G; Carreras E;
Ophthalmology; 2022 Aug; 129(8):933-945. PubMed ID: 35500608
[TBL] [Abstract][Full Text] [Related]
26. Abnormal orbital growth in children submitted to enucleation for retinoblastoma treatment.
Chojniak MM; Chojniak R; Testa ML; Min TT; Guimarães MD; Barbosa E Silva AM; Antoneli CB
J Pediatr Hematol Oncol; 2012 Apr; 34(3):e102-5. PubMed ID: 22258347
[TBL] [Abstract][Full Text] [Related]
27. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
28. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of Retrobulbar optic nerve invasion.
Wang YZ; Zhang Y; Huang DS; Shi JT; Ma JM; Li B; Xu XL; Zhou Y; Gu HL
BMC Ophthalmol; 2021 Jan; 21(1):38. PubMed ID: 33446150
[TBL] [Abstract][Full Text] [Related]
30. Delayed metastasis in patients with intraocular retinoblastoma: A review of three cases.
Vempuluru VS; Jakati S; Kaliki S
Eur J Ophthalmol; 2021 Jul; 31(4):2042-2047. PubMed ID: 32703017
[TBL] [Abstract][Full Text] [Related]
31. Treatment of retinoblastoma in Sub-Saharan Africa: Experience of the paediatric oncology unit at Gabriel Toure Teaching Hospital and the Institute of African Tropical Ophthalmology, Bamako, Mali.
Traoré F; Sylla F; Togo B; Kamaté B; Diabaté K; Diakité AA; Diall H; Dicko F; Sylla M; Bey P; Desjardins L; Gagnepain-Lacheteau A; Coze C; Harif M; Doz F
Pediatr Blood Cancer; 2018 Aug; 65(8):e27101. PubMed ID: 29697190
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic observation of 465 patients with retinoblastoma with optic nerve invasion].
Wang Y; Huang D; Shi J; Ma J; Zhao J; Li B; Xu X; Hu H; Zhou Y
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):109-13. PubMed ID: 25876685
[TBL] [Abstract][Full Text] [Related]
33. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
34. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
35. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
36. Survival in extra-orbital metastatic retinoblastoma:treatment results.
Leal-Leal CA; Rivera-Luna R; Flores-Rojo M; Juárez-Echenique JC; Ordaz JC; Amador-Zarco J
Clin Transl Oncol; 2006 Jan; 8(1):39-44. PubMed ID: 16632438
[TBL] [Abstract][Full Text] [Related]
37. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma.
Heimann H; Bechrakis NE; Zepeda LC; Coupland SE; Hellmich M; Foerster MH
Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):123-8. PubMed ID: 15778666
[TBL] [Abstract][Full Text] [Related]
38. A 20-year audit of retinoblastoma treatment outcomes.
Gündüz AK; Mirzayev I; Temel E; Ünal E; Taçyıldız N; Dinçaslan H; Köse SK; Özalp Ateş FS; Işık MU
Eye (Lond); 2020 Oct; 34(10):1916-1924. PubMed ID: 32376976
[TBL] [Abstract][Full Text] [Related]
39. The effect of enucleation on orbital growth in patients with retinoblastoma.
Oatts JT; Robbins JA; de Alba Campomanes AG
J AAPOS; 2017 Aug; 21(4):309-312. PubMed ID: 28630028
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma].
Deng X; Cheng Y; Zhu XM; Linghu DD; Zhao MW; Liang JH
Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):681-687. PubMed ID: 32907301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
